 RespireRx Pharmaceuticals OTCQB:RSPI Inc is a tiny company with huge ambitions as it advances a portfolio of innovative drugs to combat neurological and psychiatric conditions, which affect millions around the world. With a market cap of US1.7 million, it is focused on conditions where there is a poorly or unmet need and aims to develop treatments, based on modifying neurotransmission brain signalling, which have advantages to currently available drugs, if there are any. 